Clinical trial
A Prospective, Longitudinal, Multi-modal Study Evaluating the Utility of Acute Phase UFR (IVUS-FFR) to Predict Functional Significance in the Stable Phase for Patients With Acute Coronary Syndrome (ACS)
NCT07264881 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Longitudinal, Multi-modal Study Evaluating the Utility of Acute Phase UFR (IVUS-FFR) to Predict Functional Significance in the Stable Phase for Patients With Acute Coronary Syndrome (ACS)
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 2, 2025
- Completion date
- June 22, 2028
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acs (acute coronary syndrome), microvascular obstruction (mvo), multivessel coronary artery disease, st elevation myocardial infarction (stemi)